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NFAT5 represses canonical Wnt signaling via
inhibition of b-catenin acetylation and participates in
regulating intestinal cell differentiation
Q Wang1,2, Y Zhou1,2, P Rychahou1,2, C Liu2,3, HL Weiss1,2,4,5 and BM Evers*,1,2
The intestinal mucosa undergoes a continual process of proliferation, differentiation, and apoptosis, which is regulated by
multiple signaling pathways. The Wnt/b-catenin pathway has a critical role in this process. Previously, we have shown that the
calcineurin-dependent nuclear factor of activated T cell (NFAT) is involved in the regulation of intestinal cell differentiation, as
noted by the alteration of brush-border enzyme intestinal alkaline phosphatase (IAP) activity. Here, we show that calcineurin-
independent NFAT5 interacts with b-catenin to repress Wnt signaling. We found that overexpression of NFAT5 inhibits, whereas
knockdown of NFAT5 increases, TOPflash reporter activity and the expression of Wnt/b-catenin target genes, suggesting that
NFAT5 inhibits Wnt signaling. In addition, we demonstrated that NFAT5 directly interacts with the C-terminal transactivation
domain (TAD) of b-catenin, inhibits CBP interaction with b-catenin, and inhibits CBP-mediated b-catenin acetylation. Moreover,
NFAT5 is expressed in the mucosa of human intestine, with the most pronounced staining in the most differentiated region near
the epithelial surface. Knockdown of NFAT5 attenuated sodium butyrate (NaBT)-mediated induction of IAP and sucrase
activities; overexpression of NFAT5 induced IAP promoter activity. In summary, we provide evidence showing that NFAT5 is a
regulator of Wnt signaling. Importantly, our results suggest that NFAT5 regulation of intestinal cell differentiation may be through
inhibition of Wnt/b-catenin signaling.
Cell Death and Disease (2013) 4, e671; doi:10.1038/cddis.2013.202; published online 13 June 2013
Subject Category: Cancer
The mammalian intestinal mucosa undergoes a process
of continual renewal, characterized by active proliferation of
stem cells localized near the base of the crypts, progression
of these cells up the crypt–villus axis with cessation of
proliferation, and subsequent differentiation into one of the
four primary cell types (that is, enterocytes, goblet cells,
Paneth cells, and enteroendocrine cells).1 In the process of
differentiation, enterocytes acquire structural features of
mature cells, such as microvilli, and express specific gene
products, such as intestinal alkaline phosphatase (IAP) and
sucrase, brush-border enzymes.2 Differentiated enterocytes,
which make up the majority of the cells of the gut mucosa, then
undergo a process of programmed cell death (that is,
apoptosis) and are extruded into the lumen. The cellular
mechanisms regulating this tightly regimented process have
not been clearly defined. Delineating the molecular factors
regulating intestinal proliferation and differentiation is crucial
to our understanding of not only normal gut development and
maturation, but also aberrant gut growth.
The nuclear factor of activated T cell (NFAT) family proteins
are evolutionarily related to the REL (also known as c-Rel)–
nuclear factor-kB (REL–NF-kB) family of transcription factors.
Five NFAT family members have been identified: NFAT1
(NFATc2 or NFATp), NFAT2 (NFATc1 or NFATc), NFAT3
(NFATc4), NFAT4 (NFATc3 or NFATx), and NFAT5 (tonicity
enhancer binding protein (TonEBP)). NFAT proteins contain
an amino-terminal transactivation domain (TAD), a regulatory
domain (the NFAT homology region (NHR), a highly
conserved DNA-binding domain (the Rel-homology domain
(RHD), and a C-terminal domain.3,4 NFAT proteins are
involved in multiple biological processes, ranging from
lymphocyte activation and development to cardiac hypertro-
phy.5,6 NFAT has been shown to regulate cell differentiation
and development in a number of cell types.7–10 NFAT5 has a
large C-terminal region that harbors a hypertonicity-sensitive
TAD such that hyperosmotic stress can also activate NFAT5.
Unlike NFAT1–4 proteins, the NFAT5 subcellular distribution
and its phosphorylation state are not altered by calcineurin.
NFAT5 has been implicated in diverse processes such as
embryonic development, cellular migration, and prolifera-
tion.11 However, the function of NFAT5 in intestinal cells is
largely undefined.
The Wnt/b-catenin signaling pathway has a central role for
intestinal homeostasis. Wnt/b-catenin signaling is essential
for maintaining the epithelial proliferative compartment.12
Moreover, Wnt signaling controls the differentiation of
enterocytes, Paneth cells, goblet cells, and enteroendocrine
cells.13–15 Two Wnt pathways has been identified: canonical
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or Wnt/b-catenin pathway, and a noncanonical pathway or
b-catenin-independent pathway.16 In the canonical pathway,
Wnt binding leads to the stabilization of b-catenin, which
enters the nucleus to regulate Wnt pathway-target genes. Wnt
activation also acts through b-catenin-independent, nonca-
nonical pathways, such as the planar cell polarity (PCP)
pathway and a pathway involving Ca2þ signaling. Mutations
in the Wnt/b-catenin signaling pathway have been found in
most colorectal cancers.16
Previously, we have shown that NFATc1, NFATc4, and
NFATc3 participate in the regulation of intestinal cell
differentiation through regulating PTEN (NFATc1, NFATc4)
and REDD1 (NFATc3) expression. In our current study,
we found that calcineurin-independent NFAT5 inhibits
Wnt/b-catenin signaling through interaction with b-catenin.
NFAT5 binds to the b-catenin transactivation C-terminal
domain and prevents CBP interaction with b-catenin,
thus inhibiting b-catenin acetylation and Wnt/b-catenin
activation. Furthermore, silencing of NFAT5 attenuates
sodium butyrate (NaBT)-induced intestinal cell differentiation,
as shown by decreased IAP and sucrase activities. Our
results demonstrate that NFAT5 has an important role in the
regulation of Wnt/b-catenin signaling. NFAT5 may regulate
intestinal cell differentiation via the inhibition of the
Wnt/b-catenin pathway.
Results
NFAT5 inhibits Wnt/b-catenin signaling. Previously, we
have shown that activation of three calcium-dependent NFAT
isoforms, NFATc1, NFATc3, and NFATc4, contributes to
intestinal cell differentiation.7,8 It has been previously
reported that a calcineurin-independent active XNF-AT
mutation inhibited anterior development of the primary axis,
whereas a dominant negative XNF-AT mutation induced
ectopic dorsal axis formation and expression of the canonical
Wnt signaling target molecules.17 In our current study, we
investigated the role of NFAT5, a calcium-independent NFAT
isoform, in the regulation of Wnt/b-catenin signaling and
intestinal cell differentiation. The TOPflash plasmid contains
a luciferase reporter under the control of three copies of the
TCF/LEF-binding element upstream of the thymidine kinase
minimal promoter, and it is specifically regulated by Wnt/b-
catenin signaling.18 We transiently transfected either TOP-
flash or FOPflash (negative control containing mutated TCF/
LEF-binding sites) plasmids into human embryonic kidney
(HEK) 293 cells or the human intestinal cell line Caco-2. As
shown in Figure 1a, overexpression of NFAT5 inhibited
TOPflash reporter activity. Moreover, knockdown of NFAT5
increased TOPflash reporter activity in HEK293 and Caco-2
cells, and enhanced Wnt3a-stimulated TOPflash reporter
activity in HEK293 cells.
To further confirm the NFAT5 regulation of Wnt signaling,
the expression of Wnt/b-catenin target genes, SP5 and c-myc,
was analyzed by quantitative real time RT-PCR. Consistent
with the changes in TOPflash reporter activity, knockdown of
NFAT5 increased both basal and Wnt3a-stimulated SP5 and
c-myc mRNA expression (Figure 1b). Our results suggest a
role of NFAT5 in the regulation of Wnt signaling.
To examine whether NFAT5 inhibits Wnt signaling by
regulating b-catenin nuclear accumulation or localization, we
used western blots to analyze cytoplasmic and nuclear
b-catenin levels in HEK293 cells with overexpression of
NFAT5 (Figure 1c). Overexpression of NFAT5 did not affect
either cytoplasmic or nuclear b-catenin levels, suggesting that
NFAT5 may repress Wnt signaling by regulation of b-catenin
transactivation.
NFAT5 interacts with b-catenin. Wnt/b-catenin signaling
can be regulated at multiple steps (for example, regulation
of b-catenin protein levels, b-catenin nuclear localization,
b-catenin/TCF interaction, or interactions between b-catenin
and transcriptional mediator proteins).19 Our results have
shown that NFAT5 has no effect on b-catenin protein levels
or its localization (Figure 1c). To determine whether NFAT5
interferes with b-catenin transactivation, we next assessed
NFAT5 interaction with b-catenin. Myc-tagged NFAT5 and
FLAG-tagged b-catenin were co-transfected into HEK293
cells, and an immunoprecipitation assay was performed. As
shown in Figures 2a and b, the interaction between NFAT5
and b-catenin was detected. To confirm that endogenous
NFAT5 binds b-catenin, NFAT5 was immunoprecipitated
from the lysates of HEK293 or Caco-2 cells, and the
presence of b-catenin in the immunoprecipitate was detected
by western blot (Figure 2c). Our data suggest that NFAT5
interacts with b-catenin, thus repressing Wnt/b-catenin
activation.
b-Catenin has several functional domains; the N-terminal
domain controls b-catenin stability, the central armadillo
domains interact with TCF/LEF and E-cadherin, and the
C-terminal domain interacts with the transcriptional mediator
complex and activates gene transcription.20 To further
analyze which domains of b-catenin bind NFAT5, we used
several b-catenin deletion mutants (Figure 2d). HEK293 cells
were transfected with these mutants, the Myc-tagged
b-catenin mutant proteins were immunoprecipitated and
NFAT5 was detected by western blot. As shown in
Figure 2e, The N-terminus deletion mutant (Myc-cat-D-N),
or the armadillo deletion mutant (Myc-cat-D-arm), bound
NFAT5, whereas no binding of the C-terminus deletion mutant
was detected. These results demonstrate that NFAT5 binds to
the C-terminal domain of b-catenin protein.
To further confirm the direct interaction between NFAT5
and the C-terminal domain of b-catenin protein, we performed
an in vitro binding assay using purified b-catenin proteins
(Figure 2f).21 As shown in Figure 2d, b-catenin WT interacts
with NFAT5, as expected. However, in vitro binding assays
using b-catenin C-terminal domain-deletion mutants did not
demonstrate pull down of NFAT5 protein. We used glu-
tathione S-transferase (GST) as a negative control and
showed no binding to NFAT5. Considering that the C-terminal
domain interacts with the transcriptional mediator complex
and activates gene transcription,20 our results suggest that
NFAT5 may suppress the function of the b-catenin C-terminal-
transactivating domain.
NFAT5 inhibits binding between b-catenin and p300/
CBP. Once Wnt is activated, b-catenin recruits transcrip-
tional co-activators such as p300/CBP and transactivates
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Figure 1 NFAT5 regulates Wnt/b-catenin signaling. (a) Effects of NFAT5 on TCF/b-catenin reporter activity. HEK293 and Caco-2 cells were co-transfected with TOPflash
reporter plasmid or FOPflash-negative control plasmid together with either empty vector, Myc-NFAT5 or Flag-b-catenin alone or Myc-NFAT5 plus Flag-b-catenin, and the
transfected cells were incubated for 48 h (upper panels). HEK293 and Caco-2 cells were transfected with control siRNA or siRNA targeting NFAT5. After a 48-h incubation, cells
were transfected with TOPflash reporter plasmid or FOPflash-negative control plasmid. Twenty-four hours after retransfection, cells were incubated with control-conditioned
medium or Wnt3a-conditioned medium for additional 12 h (middle panels). Cells were harvested and luciferase activity was measured in the crude cell lysates, as described in
Materials and Methods. All results were normalized for transfection efficiency using the pRL-Tk-luc plasmid (Promega). Fold induction corresponds to luciferase activity of
positive TOPflash reporter over negative FOPflash reporter. (Data represent mean±S.D.; *Po0.01 versus control vector or control siRNA; #Po0.01 s Flag-b-catenin alone or
Wnt3a plus control siRNA, as determined by analysis of variance). The knockdown of NFAT5 was confirmed by western blot (lower panels). (b) Knockdown of NFAT5 increased
mRNA expression of SP5 and c-myc, downstream targets of Wnt/b-catenin signaling. HEK293 and Caco-2 cells were transfected with control siRNA or siRNA targeting NFAT5.
After a 48-h incubation, transfected cells were incubated with control-conditioned medium or Wnt3a-conditioned medium for additional 12 h. Total RNA was extracted, and SP5
and c-myc mRNA levels were determined by real time RT-PCR. (Data represent mean±S.D.; *Po0.01 versus control siRNA; #Po0.01 versus Wnt3a plus control siRNA, as
determined by analysis of variance). (c) Overexpression of NFAT5 does not alter cytoplasmic or nuclear b-catenin levels. HEK293 cells were transfected with empty vector or
Myc-NFAT5. After 48 h of transfection, cytosolic and nuclear proteins were extracted and expression of b-catenin was detected by western blot
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Wnt target gene expression.20 To determine whether NFAT5
interferes with the interaction between b-catenin and p300/
CBP, we incubated HA-tagged CBP with GST-b-catenin
protein together with or without Myc-tagged NFAT5 and
performed a GST pull-down assay. As shown in Figure 3a,
b-catenin interacts with CBP, as expected. However,
overexpression of NFAT5 effectively blocked the ability of
b-catenin to interact with CBP. We used GST as a negative
control and showed no binding to CBP (data not shown).
Next, we performed a similar experiment using the CH3
domain of p300 incubated with Flag-tagged b-catenin,
together with or without Myc-tagged NFAT5. As shown in
Figure 3B, b-catenin interacts with the CH3 domain of p300
and consistent with our previous results, overexpression of
NFAT5 effectively blocked the ability of b-catenin to interact
with the CH3 domain. Our results from these in vitro
experiments indicate that NFAT5 inhibits b-catenin interac-
tion with p300/CBP.
To test whether NFAT5 could inhibit in vivo binding between
b-catenin and CBP, HEK293 cells were co-transfected with
HA-tagged CBP and Flag-tagged b-catenin or together with
Myc-tagged NFAT5 (Figure 3c). After immunoprecipitation
using an anti-HA antibody, the interaction between b-catenin
and CBP was detected, as expected. However, overexpres-
sion of NFAT5 effectively attenuated this interaction
(Figure 3c). Together, these data suggest that NFAT5
interferes with the binding between b-catenin and p300/
CBP, thus repressing Wnt/b-catenin activation.
Figure 2 NFAT5 interacts with b-catenin. (a and b) NFAT5 interacts with b-catenin. HEK293 cells were co-transfected with Myc-tagged NFAT5 and empty vector or Flag-
tagged b-catenin, and incubated for 48 h. After anti-Flag (a) or anti-Myc (b) immunoprecipitation, the presence of NFAT5 and b-catenin were analyzed using anti-Myc and anti-
Flag antibodies, respectively. Western blot was performed on cell lysate as a control. (c) Interaction between endogenous NFAT5 and b-catenin. Endogenous NFAT5 was
immunoprecipitated from HEK293 or Caco-2 cells, and Western blot was performed on the eluate. IgG was used as a negative control. (d) Schematic diagram of b-catenin
deletion constructs. The yellow boxes are armadillo repeats. (e) C-terminal-transactivating domains of b-catenin bind NFAT5. HEK293 cells were co-transfected with Myc-
tagged b-catenin deletion mutants. Myc-tagged b-catenin mutants were immunoprecipitated using an anti-Myc antibody. Expression of NFAT5 was analyzed by western blot
with an anti-NFAT5 antibody. The expression of these b-catenin mutants was analyzed by western blot with an anti-Myc antibody. Western blot was performed on cell lysate as
a control. (f) Schematic diagram of the wild-type and mutant derivatives of GST- tagged b-catenin. (g) NFAT5 directly interacts with b-catenin. HEK293 cells were transfected
with Myc-NFAT5 and after 48 h incubation, lysate was collected and incubated with the GST protein or GST-tagged b-catenin wide type (WT) or mutant proteins. After several
washings, bound proteins were eluted and western blot assay was performed using an anti-Myc antibody
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NFAT5 inhibits acetylation of b-catenin by p300/CBP.
b-catenin is acetylated by p300/CBP.22,23 We found that
NFAT5 interferes with interactions between b-catenin and
p300/CBP. To determine whether NFAT5 inhibits b-catenin
acetylation, HEK293 cells were co-transfected with HA-
tagged CBP and Flag-tagged b-catenin, together with or
without Myc-tagged NFAT5. Flag-tagged b-catenin was
immunoprecipitated and the acetylated b-catenin was
detected by western blot assay using an anti-acetyl-lysine
antibody. As shown in Figure 4, b-catenin was acetylated by
CBP as expected, and coexpression of NFAT5 effectively
attenuated the acetylation of b-catenin. Because acetylation
of v-catenin results in the increased affinity of b-catenin to
Tcf4 and increased b-catenin transcriptional activity,22
our results demonstrate that NFAT5 interferes with the
interaction between b-catenin and p300/CBP, resulting
in decreased b-catenin acetylation and therefore, inhibits
b-catenin transcriptional activity.
NFAT5 is involved in the regulation of intestinal cell
differentiation. Epithelial cells of the intestinal mucosa
undergo a continual process of proliferation, differentiation,
and apoptosis. The Wnt/b-catenin pathway has a critical role
in this process. Inhibition of Wnt/b-catenin signaling has been
shown to induce intestinal cell differentiation.13 Human
intestinal cell lines Caco-2 and HT29 display a multipotent
phenotype, characterized by differentiation into a polarized
monolayer and expression of the brush-border enzymes,
IAP, and sucrase, when treated with the short-chain fatty
acid NaBT.24 We have shown that NFAT5 inhibited Wnt/b-
catenin signaling in HEK293 and Caco-2 cells. To determine
whether NFAT5 regulates differentiation, we first transfected
Caco-2 cells with control siRNA or NFAT5 siRNA and treated
with NaBT. Treatment with NaBT increased IAP and sucrase
activities (Figure 5a); this induction was blocked by transfec-
tion with NFAT5 siRNA. To further demonstrate the role of
NFAT5 in the regulation of intestinal cell differentiation,
Caco-2 cells were transfected with Myc-NFAT5, together
with an IAP promoter reporter construct. As shown in
Figure 5b, overexpression of NFAT5 resulted in an induction
of IAP promoter activity, further suggesting that NFAT5
contributes to the differentiation. To determine whether the
effect of NFAT5 noted in Caco-2 cells also occurs in other
intestinal cell lines, HT29 cells were transfected with control
Figure 3 NFAT5 inhibits binding between b-catenin and p300/CBP. (a) HEK293 cells were transfected with HA-CBP, Myc-NFAT5, or both, and after 48 h, lysate was
collected and incubated with the GST-tagged b-catenin protein. After several washings, bound proteins were eluted and an anti-HA western blot assay was performed.
(b) HEK293 cells were transfected with Flag-b-catenin, Myc-NFAT5, or both, and after 48 h, lysate was collected and incubated with the GST-tagged CH3 domain of p300.
After several washings, bound proteins were eluted and an anti-Flag western blot assay was performed. (c) HEK293 cells were transfected with HA-tagged CBP and
Flag-tagged b-catenin, with or without Myc-NFAT5 as indicated. Anti-HA immunoprecipitation was performed on the cell lysate, and bound proteins were analyzed via
anti-Flag western blot. Whole-cell lysate was analyzed as a control.
Figure 4 NFAT5 inhibits acetylation of b-catenin. HEK293 cells were transfected
with Flag-b-catenin, HA-CBP, and Myc-tagged NFAT5 constructs, as indicated. After
48 h, cells were lysed and Flag-tagged b-catenin was immunoprecipitated using anti-
Flag antibody. After several washings, the acetylated and total b-catenin and bound
CBP and NFAT5 were analyzed by western blot using antibodies against acetylated
lysine, Flag, HA, and Myc (top). Whole-cell lysate was analyzed as control (bottom)
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siRNA or NFAT5 siRNA, and treated with NaBT. Treatment
with NaBT increased IAP activity (Figure 5c); this induction
was blocked by knockdown of NFAT5. Together, these
results demonstrate the regulation of intestinal cell differ-
entiation by NFAT5.
Our findings demonstrate that NFAT5 has an important role
in the regulation of the Wnt/b-catenin signaling pathway and
intestinal cell differentiation. Finally, to determine the location
of NFAT5 expression in vivo, sections of normal human colon
(Figure 5d) and small intestine (Figure 5e) were obtained from
adult patients and analyzed. Interestingly, intense staining for
NFAT5 was located in the upper part of the crypt in the colon
and the villus fraction of the small intestine. Little staining of
NFAT5 was noted in the crypt cells of the small intestine.
Therefore, these findings demonstrate that NFAT5 is loca-
lized specifically in the more differentiated portions of the
intestinal mucosa, thus further suggesting the association of
NFAT5 with intestinal differentiation.
Discussion
Our previous studies demonstrated that activation of calcium-
dependent NFAT contributes to intestinal cell differentia-
tion.8,25 In addition, inhibition of Wnt/b-catenin signaling
induces intestinal cell differentiation.13 In this current study,
we provide evidence that calcium-independent NFAT5
binds b-catenin and interferes with the interaction between
b-catenin and p300/CBP. Moreover, we demonstrate that
NFAT5 blocks p300/CBP-mediated acetylation of b-catenin.
As b-catenin acetylation has an important role in the
regulation of b-catenin stability, transcriptional activity, and
the affinity of b-catenin for Tcf4,22,23,26 our results demon-
strate that NFAT5 inhibits Wnt/b-catenin through the inhibition
of b-catenin acetylation. Consistent with these results, knock-
down of NFAT5 attenuates IAP and sucrase enzyme
activities, which are markers of enterocyte differentiation. In
addition, NFAT5 is mainly expressed in the more differen-
tiated portions of the intestinal mucosa. Taken together, our
results suggest that intestinal cell differentiation is regulated
by the NFAT5/Wnt/b-catenin signaling pathway.
NFAT5 represses b-catenin signaling, but does not
obviously affect b-catenin protein levels, suggesting NFAT5
regulation of Wnt signaling downstream of b-catenin. Indeed,
we found that NFAT5 specifically interacted with the b-catenin
C-terminus, which contains the transcriptional activation
domain. The b-catenin C-terminus interacts with transcrip-
tional mediators such as p300/CBP.20 Similar to NFAT5,
KLF4 and inhibitor of b-catenin and Tcf (ICAT), which also
bind the b-catenin C-terminus, inhibit b-catenin/p300 binding
and b-catenin transcriptional activity.23,27 It is likely that
NFAT5 may inhibit b-catenin function by preventing b-catenin
binding to transcription mediators.
Calcium-dependent NFAT has been shown to repress Wnt
signaling through RHD binding to Dvl.28 As NFAT5 also has
an RHD, NFAT5 may also inhibit Wnt signaling via interaction
with Dvl. Although we have had difficulty to detect the effect of
Figure 5 NFAT5 regulation of intestinal cell differentiation. (a) Knockdown of NFAT5 attenuated NaBT-induced IAP and sucrase activities in Caco-2 cells. Caco-2 cells
were transfected with control siRNA or siRNA targeting NFAT5. After a 24-h incubation, transfected cells were treated with NaBT (5 mM) for additional 72 h. Cells were lysed
and alkaline phosphatase and sucrase activities were determined. (Data represent mean±S.D.; *Po0.05 versus control siRNA; #Po0.01 versus NaBT plus control siRNA,
as determined by analysis of variance). (b) Overexpression of NFAT5 increased alkaline phosphatase promoter activity in Caco-2 cells. Caco-2 cells were co-transfected with a
plasmid containing the intestinal alkaline phosphatase promoter fragment linked to the luciferase reporter gene and Myc-NFAT5 or empty vector. After a 48-h incubation, the
transfected cells were harvested and luciferase activity was measured in the crude cell lysates, as described in Materials and Methods. All results were normalized for
transfection efficiency using the pRL-Tk-luc plasmid (Promega). (Data represent mean±S.D.; *Po0.01 versus control). (c) Knockdown of NFAT5 attenuated NaBT-induced
IAP activity in HT29 cells. HT29 cells were transfected with control siRNA or siRNA targeting NFAT5. After a 24-h incubation, transfected cells were treated with NaBT (5 mM)
for additional 24 h. Cells were lysed and alkaline phosphatase activity was determined. (Data represent mean±S.D.; *Po0.05 versus control siRNA; #Po0.01 versus NaBT
plus control siRNA, as determined by analysis of variance).(d and e) Immunohistochemical analysis of NFAT5 protein expression in normal human colon (d) and small
intestine (e). Tissue sections were fixed and stained with primary anti-human NFAT5 antibody. NFAT5 is mainly expressed in the differentiated region (that is, upper crypts and
villus; arrows)
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NFAT5 knockdown on the Wnt3a-induced Dvl2 phosphoryla-
tion, we have detected the interaction between NFAT5 and
Dvl2 (Supplementary Figure 1). Therefore, we cannot exclude
that the effect of NFAT5 on Wnt signaling may not be
dependent on the NFAT5–Dvl interaction. It is possible that
NFAT5 may bind to not only b-catenin, but also Dvl isoforms
and thus inhibit Wnt signaling. Whether Dvl participates in
NFAT5 regulation of Wnt signaling remains to be defined.
NFAT5 has been implicated in the signaling pathways
regulating cell differentiation of various cell types.29,30 Our
results showed that NFAT5 inhibits b-catenin signaling and
participates in the regulation of intestinal cell differentiation.
Moreover, we showed that NFAT5 is mainly expressed in the
upper crypt portion of the colon and the villus fraction of the
small intestine. As the cells reach the midcrypt region, b-
catenin/TCF activity is downregulated, and this results in cell
cycle arrest and differentiation.31 Similarly, KLF4 is expressed
in the villi, and the interaction of KLF4 and b-catenin inhibits b-
catenin transcriptional activity and regulates intestinal home-
ostasis.13 A similar physiological pattern may occur with the
interaction between NFAT5 and b-catenin. The intense staining
for NFAT5 located in the more differentiated portions of the
intestinal mucosa further suggests that NFAT5 contributes to
the maintenance of intestinal homeostasis by preventing
activation of b-catenin signaling in differentiated intestinal cells.
We showed evidence for NFAT5 repression of Wnt/b-catenin.
However, we found that knockdown of NFAT5 did not alter
intestinal cell proliferation (Wang QD et al., unpublished data). It
has been reported that NFAT5-deficient lymphocytes and renal
cells showed decreased proliferation under hypertonic stress,
whereas reduction in NFAT5 activity has no apparent alteration
of proliferation in isotonic medium.32 In addition, NFAT5 has
been implicated in the regulation of the moderate osmotic-
stress-induced expression of several cyclins.33 These findings
suggest an osmotic-dependent regulation of cell proliferation by
NFAT5. NFAT5 is not only regulated by tonicity, but it can also
be activated by various tonicity-independent stimuli in hyper-
tonic and isotonic tissues.34 How NFAT5 is regulated in the
intestinal cells remains to be defined. Moreover, as we detected
NFAT5 expression mainly in the differentiated region of human
intestinal mucosa, NFAT5 may likely inhibit Wnt/b-catenin upon
the intestinal cell differentiation and contribute to the main-
tenance of intestinal homeostasis. Whether NFAT5 has
different role in the proliferating and differentiated intestinal
cells are yet to be answered.
Mice lacking NFAT5 have dramatically reduced embryonic
viability between days E13.5 and E17.5, and significant
perinatal lethality due to kidney defects32,35 and impaired
cardiac development and function.36 However, there is no
information demonstrating the resultant intestinal phenotypes
in these mice. Interestingly, Ca2þ released from the
sarcoplasmic reticulum and the removal of cytoplasmic
Ca2þ were increased in cardiomyocytes, with NFAT5
deficiency compared with that of wild-type cells.36 As Ca2þ
signaling can suppress canonical Wnt activity during axis
formation of the Xenopus embryo through the activation of
NFAT,17 it is possible that NFAT5 represses Wnt/b-catenin
signaling via the regulation of intracellular Ca2þ signaling.
The role of NFAT5 in the differentiation of other cell types has
been demonstrated.29,37 In this study, we show for the first
time that NFAT5 signaling is associated with intestinal cell
differentiation. To better understand the role of NFAT5 in
intestinal development, it will be necessary to generate
intestinal-specific knockout mice to dissect the in vivo function
of NFAT5 in the intestine.
The cross-talk between NFAT and Wnt has been shown in
some cell types and in Xenopus embryos.17,38,39 NFAT can
function as the downstream target of Wnt. Apart from the
canonical Wnt signaling pathway, activation of which leads to
nuclear accumulation of the Lef–Tcf transcriptional co-
activator b-catenin, noncanonical Wnt pathways have been
identified, which signal independently of b-catenin. The Wnt/
Ca2þ /NFAT pathway is a noncanonical Wnt pathway.40 In the
Wnt/Ca2þ /NFAT pathway, Wnt5a-bound Frizzled (FZD), in
association with a noncanonical co-receptor, activates phos-
pholipase C (PLC) and increases concentrations of Ca2þ ,
which lead to activation of the Ca2þ–calmodulin-dependent
protein phosphatase calcineurin and its target, the transcrip-
tion factor NFAT.39 We have shown that calcineurin-indepen-
dent NFAT5 binds b-catenin and represses Wnt/b-catenin
signaling in HEK293 and human intestinal cells. In agreement
with our findings, Saneyoshi et al.17 showed that calcineurin-
independent active XNF-AT mutation inhibits, whereas a loss-
of-function dominant-negative XNF-AT mutation induces
canonical Wnt signaling in Xenopus embryos. In addition,
Huang et al.28 has shown that calcineurin-dependent NFAT
represses canonical Wnt signaling via interaction with Dvl
protein. Collectively, our present study as well as those of
others identifies NFATs as important repressors for Wnt/b-
catenin. In contrast to these findings, Adachi et al.41 showed
that DMSO-induced-TOPflash reporter activity was attenu-
ated in cardiac P19CL6 cells, with overexpression of a
dominant negative mutant of NFAT5. These conflicting results
may be explained by differences in cell type and the fact that
common signaling mechanisms may be interpreted differ-
ently, depending on the cellular context.
In conclusion, our results demonstrate that the NFAT5
inhibits Wnt/b-catenin signaling through the regulation of
b-catenin acetylation. In the normal intestine, b-catenin
regulates cell proliferation in the base of crypts and inhibits
enterocyte differentiation in the upper portion of crypts.
NFAT5 is expressed predominantly in differentiated epithelial
cells. Our findings suggest that NFAT5 has a critical role in
the regulation of intestinal homeostasis through alteration of
Wnt/b-catenin signaling.
Materials and Methods
Materials. NaBT, ANTI-FLAG M2 Affinity Gel, Anti-c-Myc Agarose Affinity Gel,
Monoclonal Anti-HAAgarose antibody, and antibodies against Flag, HA, Myc,
and b-actin were purchased from Sigma Chemical Co. (St. Louis, MO, USA).
Rabbit Monoclonal anti-c-Myc antibody was from Epitomics Inc. (Burlingame, CA,
USA). Rabbit polyclonal anti-NFAT5 antibody was from Thermo Fisher Scientific
(Rockford, IL, USA). Rabbit polyclonal anti-tubulin was obtained from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Rabbit anti-b-catenin, cyclin D1, and anti-
acetylated-lysine antibodies were purchased from Cell Signaling (Beverly, MA,
USA). Mouse anti-human Top IIb (clone40/TopoIIb) was purchased from BD
Biosciences (San Diego, CA, USA). TOPflash (TCF Reporter Plasmid) and
negative control reporter FOPflash were from Millipore (Billerica, MA, USA). L cells
(ATCC CRL-2648) and L Wnt3A (ATCC CRL-2647) cell line, which were used to
obtain control-conditioned medium and Wnt3a-conditioned medium, were from
ATCC (Manassas, VA, USA).
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The plasmid encoding human Myc-tagged NFAT5 was from Alex Toker (Boston,
MA, USA). Flag-b-catenin, Myc- b-catenin mutants, HA-CBP, GST-p300 (CH3),
GST-b-catenin, and GST-b-catenin mutants have been described pre-
viously.21,23,42 Flag-Dvl2 was from Addgene (Cambridge, MA, USA). Human
NFAT5 and non-targeting control siRNA SMARTpool were purchased from
Dharmacon Inc. (Lafayette, CO, USA). siRNA SMARTpool, consisting of four siRNA
duplexes, was designed using an algorithm comprised of 33 criteria and parameters
that effectively eliminate non-functional siRNA.43
Cell culture, transfection, and treatment. HEK293 cells were cultured in
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal calf serum (FCS)
at 37 1C in 5% CO2. The human colon cancer cell line Caco-2 was maintained in
MEM supplemented with 15% of FCS. The human colon cancer cell line HT29 was
maintained in McCoy’s 5A supplemented with 10% FCS. Cells were transfected with
the siRNA duplexes and plasmids by electroporation (Gene Pulser, Bio-Rad,
Hercules, CA, USA) and Lipofectamine 2000 (Invitrogen, CA, USA), respectively, as
we have described previously.44,45 Renilla reporter pRL-null, an internal control to
normalize for variation in transfection efficiency, was transfected using Lipofectamine
2000, and the luciferase activity was determined and normalized to the Renilla activity,
as we have described previously.46 The TOPflash and FOPflash values were
normalized to Renilla, and fold induction was calculated as normalized relative light
units of TOPflash divided by normalized relative light units of FOPflash.
Western blot analysis. Nuclear and cytosolic fractions were extracted using
NE-PER Nuclear and Cytoplasmic Extraction Reagents kit (Pierce, Rockford, IL,
USA). Protein was resolved on a 10% polyacrylamide gel and transferred to PVDF
membranes. Membranes were incubated for 1 h at room temperature in blotting
solution. NFAT5, b-catenin, acetylated-lysine, Myc-tag, Ha-tag, Flag-tag, and
b-actin were detected with specific antibodies following blotting with a horseradish
peroxidase-conjugated secondary antibody, and visualized using an enhanced
chemiluminescence (ECL) detection system.
Quantitative real time RT-PCR analysis. Total RNA was extracted and
DNase-treated (RQ1, Promega, Madison, WI, USA). Synthesis of cDNA was
performed with 1mg of total RNA using the reagents in the TaqMan Reverse
Transcription Reagents Kit from ABI (no. N8080234, Foster City, CA, USA). The
TaqMan probe and primers for human SP5, c-myc, and GAPDH were purchased from
Applied Biosystems (Foster City, CA, USA). Quantitative real time RT-PCR analysis
was performed with an Applied Biosystems Prism 7000HT Sequence Detection
System using TaqMan universal PCR master mix, as we have described previously.46
GST pull-down. GST-tagged CH3 and GST-tagged b-catenin proteins were
extracted and purified as we have described previously.21,23 Briefly, GST-tagged
expression vectors were expressed in Escherichia coli, and the resultant protein
was purified with GST beads (glutathione Sepharose; Sigma). GST beads
containing purified GST-tagged protein were then incubated with cell lysate at 4 1C
for 1 h; then, beads were washed three times with lysis buffer and boiled in
1 sodium dodecyl sulfate (SDS) sample buffer, followed by analysis via western
blot, as we have described previously.23
Enzyme activity assay. Protein was extracted from cells with lysis buffer
(20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton,
2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na3VO4, 1mg/ml
leupeptin), and the concentrations of the supernatant cell lysates were determined.
The supernatant cell lysates (20 ml) were used to determine alkaline phosphatase
and sucrase activities by commercially available kits from Sigma and BioAssay
Systems, respectively, and the data were normalized by the protein amounts used,
as previously described.47
Immunohistochemical analysis. Formalin-fixed, paraffin-embedded
tissue samples of normal human colon and small intestine were used; the
samples were taken from the adjacent histologically normal colon and small
intestine removed at the time of resection for colon cancer. Tissue was processed
for routine immunohistochemical staining using antibodies against human NFAT5.
Negative controls (including no primary antibody or isotype-matched mouse
immunoglobulin G) were used in each assessment.
Statistical analysis. Descriptive statistics (mean±S.D.) were calculated and
bar graphs were generated to summarize data across different cell culture
experimental conditions. Analysis of reporter activity, IAP and sucrase activities,
IAP promoter activity, and qRT-PCR across cell culture groups were performed
using analysis of variance model and pairwise comparisons between specific
groups identified a priori were performed using contrasts from the model. All
statistical analyses were performed using SAS 9.3 (Cary, NC, USA).
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